ALternate Site Cardiac ResYNChronization (ALSYNC): A prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy

European Heart Journal

Volumn 37, Issue 27, 2016, Pages 2118-2127

  Morgan, John M ^a   Biffi, Mauro ^b   Gellér, László ^c   Leclercq, Christophe ^d   Ruffa, Franco ^e   Tung, Stanley ^f   Defaye, Pascal ^g   Yang, Zhongping ^h   Gerritse, Bart ⁱ   Van Ginneken, Mireille ⁱ   Yee, Raymond ^j   Jais, Pierre ^k  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e A MANZONI HOSPITAL   (Italy)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h Medtronic plc   (United States)

ⁱ MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^j LONDON HEALTH SCIENCES CENTRE   (Canada)

^k UNIVERSITÉ DE BORDEAUX   (France)

more..

Author keywords

Heart failure; Left ventricular endocardial pacing; Prospective clinical trial; Safety

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; WARFARIN;

AGED; ARTICLE; CARDIAC IMPLANT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CEREBROVASCULAR ACCIDENT; DEATH; ENDOCARDIUM; EPISTAXIS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART PACING; HEMATOMA; HUMAN; INFECTION; LEFT VENTRICULAR ENDOCARDIAL PACING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEW YORK HEART ASSOCIATION CLASS; PERICARDIAL EFFUSION; PNEUMOTHORAX; POCKET AEMATOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINAL ARTERY THROMBOSIS; RETROPERITONEAL HEMATOMA; SAFETY; THROMBOSIS; THROMBUS; TRANSIENT ISCHEMIC ATTACK; HEART FAILURE; HEART VENTRICLE; TREATMENT OUTCOME;

CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HEART VENTRICLES; HUMANS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84973453352     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv723     Document Type: Article

References (19)

1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.JAMA 2007; 297: 2502-2514
2. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34: 2281-2329
3. Vernooy K, Van Deursen CJ, Strik M, Prinzen FW.Strategies to improve cardiac resynchronization therapy. Nat Rev Cardiol 2014; 11: 481-493
4. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O?Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012; 59: 1509-1518
5. Bordachar P, Derval N, Ploux S, Garrigue S, Ritter P, Haissaguerre M, Jais P. Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol 2010; 56: 747-753
6. AbrahamWT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail 2000; 6: 369-380
7. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 2006; 21: 20-26
8. Garrigue S, Jais P, Espil G, Labeque JN, Hocini M, Shah DC, Haissaguerre M, Clementy J. Comparison of chronic biventricular pacing between epicardial and endocardial left ventricular stimulation using Doppler tissue imaging in patients with heart failure. Am J Cardiol 2001; 88: 858-862
9. Bracke FA, Houthuizen P, Rahel BM, Van Gelder BM. Left ventricular endocardial pacing improves the clinical efficacy in a non-responder to cardiac resynchronization therapy: role of acute haemodynamic testing. Europace 2010; 12: 1032-1034
10. Morgan JM, Scott PA, Turner NG, Yue AM, Roberts PR. Targeted left ventricular endocardial pacing using a steerable introducing guide catheter and active fixation pacing lead. Europace 2009; 11: 502-506
11. Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007; 115: 2637-2641
12. Abraham JM, Connolly SJ. Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation. Heart Fail Rev 2014; 19: 305-313
13. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012; 366: 1859-1869
14. Raghavan C, Cashion WR Jr, Spencer WH III. Malposition of transvenous pacing lead in the left ventricle. Clin Cardiol 1996; 19: 335-338
15. Rademakers LM, Van Gelder BM, Scheffer MG, Bracke FA. Mid-Term follow up of thromboembolic complications in left ventricular endocardial cardiac resynchronization therapy. Heart Rhythm 2014; 11: 609-613
16. Sung VW, Johnson N, Granstaff US, Jones WJ, Meschia JF, Williams LS, Safford MM. Sensitivity and specificity of stroke symptom questions to detect stroke or transient ischemic attack. Neuroepidemiology 2011; 36: 100-104
17. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De BM, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496
18. Derval N, Steendijk P, Gula LJ, Deplagne A, Laborderie J, Sacher F, Knecht S, Wright M, Nault I, Ploux S, Ritter P, Bordachar P, Lafitte S, Reant P, Klein GJ, Narayan SM, Garrigue S, Hocini M, Haissaguerre M, Clementy J, Jais P. Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol 2010; 55: 566-575
19. Ypenburg C, Van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ. Long-Term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009; 53: 483-490